wound care

After 1 Year as Interim COO, Exec Is Named COO of Spectral AI

by | Jun 5, 2025
Dallas-based Spectral AI said that since taking on the interim role in 2024, Stanley Micek has overseen the data science, software, hardware, imaging, and systems teams working directly on the company's FDA submission.
MORE
Dallas’ Spectral AI Appoints Chief Commercialization Officer
by | May 31, 2024

Dallas-based artificial intelligence company Spectral AI Inc. has appointed Jeremiah A. Sparks as chief commercialization officer. Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in wound care....

MORE
Spectral AI Names CEO of Its IP-Focused Subsidiary, Explores Spin Off
by | Apr 26, 2024
The largest investor in Spectral AI, Erich Spangenberg, has extensive expertise in intellectual property investment management.
MORE
Spectral AI Names Former Top MiMedx Financial Exec as CFO
by | Dec 27, 2023

Seasoned financial executive Peter M. Carlson has been hired as chief financial officer of Dallas-based Spectral AI Inc., an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care....

MORE

Spectral AI Names EVP to Spearhead UK Subsidiary, Global Expansion of Imaging Tech

by | Oct 27, 2023
Spectral AI has recently secured its largest contract to date from the U.S. government, an award exceeding $149 million, boosting its total U.S. government awards accrued since 2019 to more than $246 million, as it aims to revolutionize wound care. The company's DeepView SnapShot Wound Imaging System, has received UK Conformity Assessed (UKCA) marking for use in the United Kingdom and has been classified as a Class 1 medical device by U.S. FDA.
MORE
Spectral AI Appoints ‘High-Impact’ Healthcare Exec to its Board of Directors
by | Oct 6, 2023
In September, the firm began trading on Nasdaq and secured a BARDA Project BioShield contract worth up to $149 million.
MORE